An Introduction to COVID-19
On 11 March 2020, the World Health Organization declared COVID-19 a pandemic. The impact on the medical community has been huge, not only on the front-line but also for patients navigating treatment for endocrine conditions during this unprecedented situation.
The touchENDOCRINOLOGY expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
Cortisol and COVID-19—Putting Undue Stress on the “Stress Hormone”
US Endocrinology. 2020;16(2):66–7 DOI: https://doi.org/10.17925/USE.2020.16.2.66
We read, with great interest, the editorial entitled “Can Serum Cortisol be Used to Monitor Patients with COVID-19?”.1 The authors have discussed a novel concept regarding COVID-19; however, consideration for the practical implications of this approach seemed limited. Cortisol is a stress hormone; hence, it is expected to be elevated in patients with infections.2 The greater the […]
Can Serum Cortisol Be Used To Monitor Patients With COVID-19?
US Endocrinology. 2020;16(2):63–4 DOI: https://doi.org/10.17925/USE.2020.16.2.63
Management of patients with severe COVID-19 remains a challenge for physicians. In severe cases of COVID-19, a hyperactive innate immune response characterized by high serum levels of proinflammatory markers, known as a ‘cytokine storm’, is characteristically present. The cytokine storm induces fulminant pulmonary inflammation known as acute respiratory distress syndrome, and subsequently systemic inflammation, which […]
Short-term Hydroxychloroquine in COVID-19 Infection in People With or Without Metabolic Syndrome – Clearing Safety Issues and Good Clinical Practice
European Endocrinology. 2020;16(2):109–12 DOI: https://doi.org/10.17925/EE.2020.16.2.109
Hydroxychloroquine has been in clinical use for decades, being extensively used by rheumatologists across the globe for different autoimmune disorders (rheumatoid arthritis, lupus and Sjögren‘s syndrome, among others), across all age groups and including during pregnancy. Novel coronavirus disease (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pandemic sweeping […]
Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
European Endocrinology. 2020;16(2):88–91 DOI: https://doi.org/10.17925/EE.2020.16.2.88
The role of testosterone is well established in health and disease.1 Testosterone is known to mediate physical, mental and reproductive health. Its role has been discussed in gender-specific variations related to conditions as diverse as cardiovascular, autoimmune, psychiatric and oncological diseases.2–4 The recent coronavirus disease 2019 (COVID-19) pandemic has uncovered newer facets of testosterone action and […]
Managing Diabetes During the COVID-19 Pandemic
European Endocrinology. 2020;16(2):85–7 DOI: https://doi.org/10.17925/EE.2020.16.2.85
The coronavirus disease 2019 (COVID-19) pandemic is an occurring global public health crisis due to the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1 In December of 2019, a low respiratory tract infection of unknown cause emerged in Wuhan, Hubei Province, China. The Huanan seafood market was considered to be the main source of […]
Stefano Del Prato, EASD 2020 – Planning a virtual meeting
We were delighted to speak with EASD President Prof. Stefano Del Prato (University of Pisa and University Hospital of Pisa) ahead of this year’s virtual meeting to hear how the meeting has been adapted to a virtual format. Questions 1. How did you go about planning for virtual EASD?(00:05) 2. What key features are you […]
Challenges in Women with Diabetes During the COVID-19 Pandemic
European Endocrinology. 2020;16(2):100–8 DOI: https://doi.org/10.17925/EE.2020.16.2.100
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly to become a global health threat. The disease is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel β-coronavirus that belongs to a family of enveloped RNA viruses, the coronaviruses.1 While some of the coronaviruses cause common flu, other strains, such as SARS-CoV, Middle East respiratory syndrome […]
COVID-19: New ways of providing care
COVID-19 is forcing us to change the way we work. Professor Chantal Mathieu from Leuven, Belgium, explains how video and teleconsulting is helping her diabetes centre meet the challenge. Support: Published in collaboration with the European Association for the Study of Diabetes (EASD) Published: 15 April 2020
Obesity, diabetes and COVID-19: Challenges and how to keep safe
Dr Osama Hamdy, Harvard Medical School, discusses the greater risk to patients with obesity, diabetes, cardiovascular problems and related health issues, extra precautions to take and the impact COVID-19 is having on clinical practice. Questions 1. How do obesity and cardiovascular problems affect an individual’s susceptibility to COVID-19? (0:10) 2. In the USA, how is […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!